We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of Evobrutinib in Participants With RMS (evolutionRMS 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04338061
Recruitment Status : Active, not recruiting
First Posted : April 8, 2020
Last Update Posted : November 8, 2022
EMD Serono Research & Development Institute, Inc.
Information provided by (Responsible Party):
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 4, 2023
Estimated Study Completion Date : June 26, 2026